Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases
1. Novosibirsk State Medical University, Novosibirsk, Russia; Institute of Molecular Biology and Biophysics, Novosibirsk, Russia 2. Novosibirsk State Medical University, Novosibirsk, Russia 3. Institute of Molecular Biology and Biophysics, Novosibirsk, Russia 4. Novosibirsk State University, Novosibirsk, Russia 5. JSC “Vector-Best”, Koltsovo, Novosibirsk Region, Russia
Breast cancer, in most cases, is a malignant neoplasm associated with infiltration of a tumor with the cells that form its microenvironment and produce various cytokines. The aim of the study was to evaluate the cytokine-producing function of tumor cells and their microenvironment in biopsy specimen of patients with invasive carcinoma of no special type and in patients with benign breast diseases. To assess the cytokine-producing activity of the tumor and its microenvironment, the index of polyclonal activators influence on cytokine production by biopsy specimens of patients with invasive carcinoma of no special type (group I) and in patients with benign breast tumors (group II) was calculated. Group II was further subdivided into group IIa, which included only patients with fibroadenoma, and group IIb, which included the patients with leaf-shaped fibroadenoma, fibroadenomatosis, fibrocystic mastopathy, intraductal papillomatosis, sclerosing adenosis and fibrocystic mastopathy with microcalcifications. The concentrations of IL-2, IL-6, IL-8, IL-10, IL-17, IL-18, IL-1β, IL-1Ra, TNF-α, IFN-γ, G-CSF, GM-CSF, VEGF, and MCP-1 were measured in tumor biopsy supernatants. When comparing groups I and II, higher indices of the polyclonal activators influence on the production of IL-17, IL-18 and TNF-α were observed in patients with benign diseases. Higher indices of the polyclonal activators influence on the production of IL-18, TNF-α, and IL-1β and the ratio of IL1β/IL1Ra were observed in patients with fibroadenoma as compared to those with invasive carcinoma of no special type. There were no significant differences in the indices of the polyclonal activators influence between groups I and IIb. This suggests the existence of changes in the mammary gland in patients of group IIb similar to those present in patients with invasive carcinoma of no special type. Higher indices of polyclonal activators influence on the production of IL-1β, as well as the ratio of IL1β/IL1Ra were observed in the patients of group IIa compared to the patients of group IIb. The results of the study identify the features of the cytokine-producing resource of tumor biopsy specimens in patients with invasive carcinoma of no special type and with benign breast tumors.
Download PDF:
Keywords: cytokines, microenvironment of tumor, mammary gland patologies
Citation:
Autenshlyus A.I., Studenikina A.A., Bernado A.V., Mikhailova E.S., Proskura A.V., Sidorov S.V., Varaksin N.A., Lyakhovich V.V. (2019) Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases. Biomeditsinskaya Khimiya, 65(5), 418-423.
Autenshlyus A.I. et al. Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases // Biomeditsinskaya Khimiya. - 2019. - V. 65. -N 5. - P. 418-423.
Autenshlyus A.I. et al., "Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases." Biomeditsinskaya Khimiya 65.5 (2019): 418-423.
Autenshlyus, A. I., Studenikina, A. A., Bernado, A. V., Mikhailova, E. S., Proskura, A. V., Sidorov, S. V., Varaksin, N. A., Lyakhovich, V. V. (2019). Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases. Biomeditsinskaya Khimiya, 65(5), 418-423.
Quail D.F., Bowman R.L., Akkari L., Quick M.L., Schuhmacher A.J., Huse J.T., Holland E.C., Sutton J.C., Joyce J.A. (2016) Science, 352, 6288. CrossRef Scholar google search
Soria G., Ofri-Shahak M., Haas I., Yaal-Hahoshen N., Leider-Trejo L., Leibovich-Rivkin T., Weitzenfeld P., Meshel T., Shabtai E., Gutman M., Ben-Baruch A. (2011) BMC Cancer., 11, 130. CrossRef Scholar google search
Castells X., Domingo L., Corominas J.M., Torá-Rocamora I., Quintana M.J., Baré M., Vidal C., Natal C., Sánchez M., Saladié F., Ferrer J., Vernet M., Servitja S., Rodríguez-Arana A., Roman M., Espinàs J.A., Sala M. (2015) Breast Cancer Res. Treat., 1(149), 237-244. CrossRef Scholar google search
Posso M., Corominas J.M., Serrano L., Roman M., Torá-Rocamora I., Domingo L., Romero A., Quintana M.J., Vernet-Tomas M., Baré M., Vidal C., Sánchez M., Saladié F., Natal C., Ferrer J., Servitja S., Sala M., Castells X. (2017) Cancer Med., 6, 1482-1509. CrossRef Scholar google search
Salamat F., Niakan B., Keshtkar A., Rafiei E., Zendehdel M. (2018) Iran. J. Med. Sci., 43(4), 355-364. Scholar google search
Zendehdel M., Niakan B., Keshtkar A., Rafiei E., Salamat F. (2018) Iran. J. Med. Sci., 43(1), 1-8. Scholar google search
World Medical Association (2013) World medical association Declaration of Helsinki: Ethical principles for medical research involving human subjects association. JAMA 310, 2191-2194. CrossRef Scholar google search
Autenshlyus A., Arkhipov S., Mikhailova E., Marinkin I., Arkhipova V., Mogilnaya E., Varaksin N., Rukavishnikov M. (2017) Int. J. Immunopathol. Pharmacol., 30(3), 308-314. CrossRef Scholar google search
Park I.H., Yang H.N., Lee K.J., Kim T.S., Lee E.S., Jung S.Y., Kwon Y., Kong S.Y. (2017) Oncotarget., 8(20), 32722-32730. CrossRef Scholar google search
Nutter F., Holen I., Brown H.K., Cross S.S., Evans C.A., Walker M., Coleman R.E., Westbrook J.A., Selby P.J., Brown J.E., Ottewell P.D. (2014) Endocrine-Related Cancer, 21, 327-341. CrossRef Scholar google search
Degnim A.C., Nassar A., Stallings-Mann M., Keith Anderson S., Oberg A.L., Vierkant R.A., Frank R.D., Wang C., Winham S.J., Frost M.H., Hartmann L.C., Visscher D.W., Radisky D.C. (2015) Breast Cancer Res. Treat., 3(152), 687-694. CrossRef Scholar google search
Visscher D.W., Nassar A., Degnim A.C., Frost M.H., Vierkant R.A., Frank R.D., Tarabishy Y., Radisky D.C., Hartmann L.C. (2014) Breast Cancer Res. Treat., 1(144), 205-212. CrossRef Scholar google search
